CTIBL is mainly caused by chemotherapy with resultant ovarian failure or endocrine treatment with gonadotropin-releasing hormone [GnRH] analogs, aromatase inhibitors and tamoxifen [28]. Here, GNRH1 is linked to ovarian dysfunction.